Conference Coverage
A blood biomarker for MS: Coming to clinics soon?
DALLAS – Neurologists have lacked ways to monitor subclinical MS, but new developments suggest that blood levels of neurofilament light chain (NfL...
Conference Coverage
Cerebellar volume may predict disability in patients with relapsing-remitting MS
DALLAS – Baseline cerebellar gray matter volume was the only MRI metric that significantly predicted 25-foot walk test results at 36 months.
News
FDA approves Mavenclad for treatment of relapsing MS
Cladribine (Mavenclad) is the first short-course oral therapy for adult patients with relapsing/remitting or active secondary progressive MS.
Conference Coverage
Imaging mass cytometry sheds light on inflammation, demyelination in MS
DALLAS – The technology enables clinicians to examine multiple proteins within intact tissue and distinguish cell types based on complex...
Conference Coverage
MS researchers aim to build MRI diagnostic portfolio beyond the central vein sign
DALLAS – Evaluation of lesion morphology is one emerging technology, according to Dr. Andrew J. Solomon.
Conference Coverage
Study launched to further evaluate the central vein sign in MS
DALLAS – A total of 10 clinical sites in North America are participating, with the Cleveland Clinic coordinating.
Conference Coverage
Expert calls for more ‘ethnocentric’ research in MS
DALLAS – Understanding the effect of race/ethnicity is crucial to understanding MS disparities.
Conference Coverage
Smartphone technology helps to detect, track eye changes in MS
DALLAS – The testing is low-cost, large-scale, and enables clinicians to study genotype-phenotype comparisons.
Conference Coverage
Study eyes serious adverse events from long-term rituximab use in MS
DALLAS – No patient experienced an infusion reaction requiring hospitalization.
Conference Coverage
Optical coherence tomography emerging as a promising biomarker for MS
DALLAS – To date, there has been a paucity of studies assessing the effects of DMTs on retinal layer thickness.
Conference Coverage
New data bolster latitude’s association with MS prevalence
DALLAS – After integrating data from 94 new studies, “the latitudinal gradient in MS prevalence ... significantly enhanced in magnitude,”...
Conference Coverage
Which comorbidities most diminish quality of life in patients with MS?
DALLAS – Systemic lupus erythematosus, depression, and hyperthyroidism may have large effects on health-related quality of life in patients with...
Video
MRI is a critical part of the MS precision medicine toolkit
DALLAS – As the central vein sign emerges as a candidate biomarker, researchers are tracking very early lesions.
Conference Coverage
Survey of MS patients reveals numerous pregnancy-related concerns
DALLAS – Of those who became pregnant following diagnosis, 20% reported postpartum depression or anxiety.
Conference Coverage
Teriflunomide transmission can occur in female partners of men taking the drug
DALLAS – Women who had low detectable levels of teriflunomide did not engage in more frequent sexual intercourse than did women with undetectable...
Conference Coverage
Neurologists grappling with patients who embrace ‘stem cell tourism’
DALLAS – The unethical practice of offering unproven cellular preparations to patients is rising in multiple sclerosis.
Video
Don’t forget social determinants of health in minority MS patients
DALLAS – Keep race and ethnicity in mind when caring for patients with multiple sclerosis, says Dr. Lilyana Amezcua.
Conference Coverage
-
-
-
-
-
Study launched to further evaluate the central vein sign in MS
Multimedia
Question 1 of 5